Company Data

Aptose Biosciences Inc.

Ticker
APTO
Current Price
$0.279 63.92%
Market Cap
$5.1M
Price Target
Refer to Report
Volume
304.2M
52wk Range
$0.13 - $2.68
Advanced Market Data

Overview

Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy